Norgestrel may be a potential therapy for retinal degenerations

Author： Doonan Francesca   Cotter Thomas G  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.5, 2012-05, pp. : 579-581

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retinal Degenerations: From Cell Signaling to Cell Therapy; Pre-Clinical and Clinical Issues

By  

Current Gene Therapy, Vol. 7, Iss. 2, 2007-04 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Antiadhesion therapy may have potential in asthma

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 9, 2015-11 ,pp. : 1225-1234

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Gene Therapy for the Treatment of Inherited Retinal Degeneration

By  

Current Gene Therapy, Vol. 7, Iss. 6, 2007-12 ,pp. : 434-445

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Therapy for Retinal Vein Occlusions

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 328-336

Bentham Science Publishers

Access to resources Recommend Favorite